OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 8 citing articles:

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Jon Salmanton‐García, Francesco Marchesi, Francesca Farina, et al.
EClinicalMedicine (2024) Vol. 71, pp. 102553-102553
Open Access | Times Cited: 12

Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights
Heng Joo Ng, Maaz Kamal Alata, Quang The Nguyen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

S1-Leitlinie Nachhaltigkeit in der Intensiv- und Notfallmedizin
Matthias Kochanek, M. Berek, Sebastian Gibb, et al.
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2025)
Closed Access

Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024
Louise Cremer, Jannik Stemler, Rosanne Sprute, et al.
Blood Research (2025) Vol. 60, Iss. 1
Open Access

Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures
Maria A. Gonzalez‐Carmona, Alfred Schmitz, Moritz Berger, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13613-13613
Open Access

Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination
Chiara Callegari, Davide Lazzarotto, Alessandra Soravia, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 4, pp. 668-670
Closed Access | Times Cited: 1

COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period
Gülşen İskender, Duygu Mert, Göknür Yapar Toros, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2023) Vol. 53, Iss. 6, pp. 1744-1755
Open Access | Times Cited: 1

Page 1

Scroll to top